LYRA (Lyra Therapeutics) Rega marang bathi mangsa ngarep

Simbol resmi perusahaan Lyra Therapeutics (LYRA)

Lyra Therapeutics, Inc. (LYRA) relies on outsourcing research and production to third-party vendors for its operational efficiency. The company's forward P/E ratio on the GURU.Markets chart illustrates how the market values its strategy for implementing biodegradable implants for ENT organs, with the indicator reaching 0.00. However, the current pipeline restructuring following failed tests creates significant risks for the asset's future capitalization.

lyratherapeutics.com - Rasio kapitalisasi marang bathi mangsa ngarep LYRA (periode 04.07.2022 - 28.03.2026)

Ringkesan rincian data analitis lyratherapeutics.com (LYRA)

Pambiji fundamental:LYRA Lyra Therapeutics, Inc
Produk merek Lyra Therapeutics, Inc.

The market views the prospects of Lyra Therapeutics, Inc. (LYRA) skeptically due to failed clinical trials and a lack of stable revenue streams. The relationship between the current price and expected earnings, as illustrated by the company's forward P/E trend, reflects speculative optimism rather than fundamental value, as the cash burn transforms this indicator into a marker of high risk for a total asset write-down.

Perusahaan pesaing

Rega marang bathi mangsa ngarep haleon.com (HLN)|KVUE (Kenvue Health) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Verona Pharma PLC VRNA|Jyong Biotech (MENS) - Rasio prakiraan rega marang bathi|LGND: Prakiraan rega marang bathi|Amneal - Rasio kapitalisasi marang bathi mangsa ngarep|PRGO: Pangali Forward P/E|Alvotech Corp - Pangali mangsa ngarep rega marang bathi|LQDA (Liquidia Corp) - Pangali Forward P/E|Rasio prakiraan rega marang bathi glpg.com GLPG|Rega marang bathi mangsa ngarep ANI Pharmaceuticals, Inc. (ANIP)|MNKD (MannKind Corp) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E AMPH (Amphastar Pharmaceuticals Inc)|PCRX (Pacira) - Rasio rega marang bathi sing dikarepake|SPRY - Rega marang bathi mangsa ngarep|Pangali mangsa ngarep rega marang bathi TBPH (Theravance Biopharma)|AQST (aquestive.com) - Prakiraan rega marang bathi|Rasio rega marang bathi sing dikarepake SCPH (scPharmaceuticals, Inc.)|Prakiraan rega marang bathi TECX|Tonix Pharmaceuticals (TNXP) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E SXTC|Pangali Forward P/E Eupraxia Pharma (EPRX)|Rega marang bathi mangsa ngarep BioHarvest Sciences Inc. BHST|EXOZ - Prakiraan rega marang bathi|ORMP: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi ENTX (enterabio.com)|MindWalk Therapeutics (HYFT) - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi abvcpharma.com (ABVC)|Rega marang bathi mangsa ngarep Cumberland Pharma|Rega marang bathi mangsa ngarep QNTM|Pangali Forward P/E FGEN|TELO (Telomir Pharma) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Rani Therapeutics Holdings RANI|SNYR - Prakiraan rega marang bathi|RLYB - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi lexariabioscience.com LEXX|PULM: Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep PTHL|Rega marang bathi mangsa ngarep Aptorum Group Limited|Prakiraan rega marang bathi Impact BioMedical Inc (IBO)|Pangali Forward P/E TNFA|YCBD: Rasio rega marang bathi sing dikarepake|Rega marang bathi mangsa ngarep PainReform PRFX|altamiratherapeutics.com (CYTO) - Rasio prakiraan rega marang bathi|LIPO: Prakiraan rega marang bathi|OPTN (optinose.com) - Rasio rega marang bathi mangsa ngarep|PIRS: Pangali Forward P/E|PROC - Kapitalisasi marang proyeksi bathi|PTPI (Petros Pharma) - Pangali Forward P/E|Rega marang bathi mangsa ngarep QLI|Pangali Forward P/E SLRN|Rasio kapitalisasi marang bathi mangsa ngarep TFFP